Du är här

2016-05-25

Allenex AB: NASDAQ STOCKHOLM HAS APPROVED APPLICATION FOR DE-LISTING

Press release May 25 2016

Allenex AB (publ) announced on 20 May 2016 that the company had
decided to apply for de-listing of the Allenex share from Nasdaq
Stockholm. The application has now been approved.

The last day of trading in the Allenex share will be Wednesday 8 June
2016.

For more information please contact:
Anders Karlsson, CEO Allenex AB, and ph.: +4670-918 00 10, e-mail:
anders.karlsson@allenex.se

Allenex AB discloses the information provided herein pursuant to the
Securities Markets Act and /or the Financial Instruments Trading Act.
The information was submitted for publication on May 25, 2016, at
08.00 CET. Allenex is a life science-company that develops,
manufacture, market and sell products for safer transplants of organs
and bone marrow on the global market. Allenex is listed on NASDAQ OMX
Stockholm Small Cap (ticker: ALNX). 57 persons are employed in the
Allenex group.

-----------------------------------------------------------
http://news.cision.com/allenex-ab/r/nasdaq-stockholm-has-approved-applic...
http://mb.cision.com/Main/708/2016627/520238.pdf

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.